Rodrigo Quera

10PUBLICATIONS
55CO-AUTHORS
Immunogenetics (incl. genetic immunology)Nanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 08, 2026
Use of subcutaneous infliximab biosimilar CT-P13 in the Common Variable Immune Deficiency associated enteropathy.

|Feb 25, 2026
Comment on safety of thiopurines in inflammatory bowel diseases: neither good nor bad.

Francisca Carvajal, Rodrigo Quera, Gonzalo Pizarro

|Nov 17, 2025
Comment on: dual advanced therapy in inflammatory bowel disease. Why, when and how?

Rodrigo Quera, Paulina Núñez, Gonzalo Pizarro

|Sep 29, 2025
Monitoring inflammatory activity in inflammatory bowel disease: not too far, not too close.

Rodrigo Quera, Paulina Núñez, Francisca Carvajal

|Apr 08, 2025
It's time to measure what matters in inflammatory bowel disease.

Joaquín González Aroca, Rodrigo Quera

|Jan 11, 2024
Mesalamine induced hepatotoxicity. Is mesalamine safe?

Javier Pérez-Valenzuela, Lorena Castro Solari, Rodrigo Quera

Pageof 2

Frequent Collaborators

6 joint publications

Paulina Núñez Figueroa

3 joint publications

Luis Contreras

2 joint publications

Christian von Mühlenbrock

2 joint publications

Gonzalo Pizarro